{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:57:03Z","timestamp":1787504223185,"version":"build-2736575974"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to detect the expression of Akt, mTOR, and Pax-2 in differing endometrial tissue\/cells, together with assessment of such molecular markers for improving accuracy within endometrial cytology screening for endometrial cancer (EC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Overall, 92 hysteroscopy cases were included. This cohort comprised 32 endometrial carcinoma patients, 30 benign lesion patients, and 30 cases with normal endometrium. Endometrial cells were collected before hysteroscopy, for immunohistochemical (IHC) and immunocytochemical (ICC) detection of Akt, mTOR, and Pax-2. Expression levels were evaluated by semi-quantitative method, and ROC curves (Receiver Operating Characteristic Curve) were drawn to evaluate the application importance for all three biomarkers for EC diagnostics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      IHC expression of Akt, mTOR, and Pax-2 was positively correlated with ICC expression within the endometrial carcinoma cohort, benign lesion cohort, and normal cohort. Using IHC and ICC, Akt\/mTOR-marked upregulation was observed within the EC cohort, compared to all other cohorts. Pax-2 was also markedly upregulated within normal\/benign lesion cohorts in comparison to the EC cohort (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.01). The sensitivity and specificity of ICC was 73.33 and 91.53%, respectively, when Akt\u202f\u2265\u202f190 was used as the diagnostic index for EC. When mTOR\u202f\u2265\u202f255 was used as the diagnostic index for EC, such parameters were 84.38 and 95.00%, respectively. When Pax-2\u202f\u2264\u202f165 was used as the diagnostic index for EC, such parameters were 96.67 and 80.00%, respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This investigation probed varying threshold levels pertaining to Akt, mTOR, and Pax-2, consequently assisting in endometrial lesion-type identification. IHC within ECT (endometrial cytology test) analyses for Akt, mTOR, and Pax-2 could enhance the capacity for diagnosing EC\/pre-malignant lesions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2025.1576060","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:13:29Z","timestamp":1745799209000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Immunocytochemical examination of Akt, mTOR, and Pax-2 for endometrial carcinoma through thin-layer endometrial cytology"],"prefix":"10.3389","volume":"12","author":[{"given":"Ke","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiting","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianghui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinping","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1016\/S0140-6736(22)00323-3","article-title":"Endometrial cancer","volume":"399","author":"Crosbie","year":"2022","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1055\/a-0715-2964","article-title":"Interdisciplinary diagnosis, therapy and follow-up of patients with endometrial cancer. Guideline (S3-level, AWMF registry number 032\/034-OL, April 2018) - part 2 with recommendations on the therapy and follow-up of endometrial cancer, palliative care, psycho-oncological\/psychosocial care\/rehabilitation\/patient information and healthcare facilities","volume":"78","author":"Emons","year":"2018","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"ref4","year":"2019"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/ijgo.12608","article-title":"FIGO cancer report 2018","volume":"143","author":"Bhatla","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ejogrb.2017.04.015","article-title":"BGCS uterine cancer guidelines: recommendations for practice","volume":"213","author":"Sundar","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.6004\/jnccn.2023.0006","article-title":"Uterine neoplasms, version 1.2023, NCCN clinical practice guidelines in oncology","volume":"21","author":"Abu-Rustum","year":"2023","journal-title":"J Natl Compr Cancer Netw"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1097\/01.AOG.0000462977.61229.de","article-title":"Practice bulletin no. 149: endometrial cancer","volume":"125","year":"2015","journal-title":"Obstet Gynecol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.3802\/jgo.2017.28.e12","article-title":"Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement","volume":"28","author":"Lee","year":"2017","journal-title":"J Gynecol Oncol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.radonc.2015.11.013","article-title":"ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up","volume":"117","author":"Colombo","year":"2015","journal-title":"Radiother Oncol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1097\/AOG.0000000000001071","article-title":"Committee opinion no. 631: endometrial intraepithelial neoplasia","volume":"126","author":"Parkash","year":"2015","journal-title":"Obstet Gynecol"},{"key":"ref12","year":"2023"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00404-017-4400-2","article-title":"Liquid-based endometrial cytology associated with curettage in the investigation of endometrial carcinoma in a population of 1987 women","volume":"296","author":"Yang","year":"2017","journal-title":"Arch Gynecol Obstet"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.tjog.2015.09.006","article-title":"Liquid-based endometrial cytology associated with curettage in the investigation of endometrial carcinoma in postmenopausal women","volume":"55","author":"Ma","year":"2016","journal-title":"Taiwan J Obstet Gynecol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.19538\/j.fk2017100115","article-title":"Expert consensus on screening and early diagnosis of endometrial cancer (draft)","volume":"33","year":"2017","journal-title":"Chinese J Pract Gynecol Obstetr"},{"key":"ref16","first-page":"1269","article-title":"Current status and research progress of screening for endometrial carcinoma (in Chinese)","volume":"37","author":"Yang","year":"2021","journal-title":"Chinese J Pract Gynecol Obstetr"},{"key":"ref17","first-page":"882","article-title":"Thin-layer cytology and histopathology in the evaluation of abnormal uterine bleeding","volume":"48","author":"Garcia","year":"2003","journal-title":"J Reprod Med"},{"key":"ref18","first-page":"179","article-title":"Thin-layer cytology in endometrial diagnosis","volume":"95","author":"Buccoliero","year":"2003","journal-title":"Pathologica"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1365-2303.2004.00224.x","article-title":"The role of liquid-based cytology associated with curettage in the investigation of endometrial lesions from postmenopausal women","volume":"16","author":"Papaefthimiou","year":"2005","journal-title":"Cytopathology"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1365-2303.2007.00463.x","article-title":"Liquid-based endometrial cytology: cyto-histological correlation in a population of 917 women","volume":"18","author":"Buccoliero","year":"2007","journal-title":"Cytopathology"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/cncr.23636","article-title":"Direct uterine sampling with the Tao brush sampler using a liquid-based preparation method for the detection of endometrial cancer and atypical hyperplasia: a feasibility study","volume":"114","author":"Kipp","year":"2008","journal-title":"Cancer"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"84785","DOI":"10.18632\/oncotarget.12626","article-title":"DNA methylation promotes paired box 2 expression via myeloid zinc finger 1 in endometrial cancer","volume":"7","author":"Jia","year":"2016","journal-title":"Oncotarget"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.3390\/cancers16061159","article-title":"Biomarkers in the diagnosis of endometrial Precancers. molecular characteristics, candidate immunohistochemical markers, and promising results of three-marker panel: current status and future directions","volume":"16","author":"Niu","year":"2024","journal-title":"Cancers (Basel)"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"6225","DOI":"10.1158\/0008-5472.CAN-10-0149","article-title":"Joint loss of PAX2 and PTEN expression in endometrial precancers and cancer","volume":"70","author":"Monte","year":"2010","journal-title":"Cancer Res"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1002\/dc.20745","article-title":"A primer of endometrial cytology with histological correlation","volume":"35","author":"Maksem","year":"2007","journal-title":"Diagn Cytopathol"},{"key":"ref26","volume-title":"Tumours of the breast and female genital organs. Pathology and genetics World Health Organization classification of tumours","author":"Tavassoli","year":"2003"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3760\/cma.j.cn112152-20240119-00035","article-title":"Cancer incidence and mortality in China, 2022","volume":"46","author":"Zheng","year":"2024","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"ref28","article-title":"CQ210 appropriate collection methods for endometrial cytology and screening targets","volume-title":"Guidelines for obstetrics and gynecology practice-gynecology outpatient section","author":"JSOOA","year":"2020"},{"key":"ref29","first-page":"1050","article-title":"Expert consensus of endometial cancer screening and early diagnosis","volume":"33","year":"2017","journal-title":"Chinese J Pract Gynecol Obstetr"},{"key":"ref30","volume-title":"NCCN clinical practice guidelines in oncology: uterine neopalsms (2021.V1)","year":"2020"},{"key":"ref31","year":"2019"},{"key":"ref32","volume-title":"CQ210 adequate sampling of cytology of uterine. Guidelines for obstetrics and gynecology 2020","year":"2020"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/j.1525-1438.2006.00757.x","article-title":"Liquid-based endometrial cytology: its possible value in postmenopausal asymptomatic women","volume":"17","author":"Buccoliero","year":"2007","journal-title":"Int J Gynecol Cancer"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/j.1525-1438.2007.01019.x","article-title":"Clinical utility of liquid-based cytology for the characterization and management of endometrial polyps in postmenopausal age","volume":"18","author":"Fambrini","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1159\/000113047","article-title":"Surveillance for endometrial cancer in women on tamoxifen: the role of liquid-based endometrial cytology - cytohistological correlation in a population of 168 women","volume":"65","author":"Buccoliero","year":"2008","journal-title":"Gynecol Obstet Investig"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/cyt.12013","article-title":"Diagnostic accuracy of liquid-based endometrial cytology in the evaluation of endometrial pathology in postmenopausal women","volume":"24","author":"Remondi","year":"2013","journal-title":"Cytopathology"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"102643","DOI":"10.1016\/j.jogoh.2023.102643","article-title":"A study evaluating liquid-based endometrial cytology test and transvaginal ultrasonography as a screening tool for endometrial cancer in 570 postmenopausal women","volume":"52","author":"Yang","year":"2023","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"ref38","first-page":"884","article-title":"Endometrial cytology test in endometrial cancer screening","volume":"48","author":"Yang","year":"2013","journal-title":"Chinese J Obstetr Gynecol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.humpath.2011.08.021","article-title":"PIK3CA mutations in endometrial carcinomas in Chinese women: phosphatidylinositol 3\u2032-kinase pathway alterations might be associated with favorable prognosis","volume":"43","author":"Dong","year":"2012","journal-title":"Hum Pathol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"117481","DOI":"10.1016\/j.lfs.2020.117481","article-title":"Targeting PI3K\/Akt\/mTOR signaling pathway by polyphenols: implication for cancer therapy","volume":"255","author":"Mirza-Aghazadeh-Attari","year":"2020","journal-title":"Life Sci"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1038\/modpathol.2015.142","article-title":"How to approach the many faces of endometrioid carcinoma","volume":"29","author":"Malpica","year":"2016","journal-title":"Mod Pathol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/cyt.12095","article-title":"Cytodiagnosis of endometrial carcinoma and hyperplasia on imprint smears with additional immunocytochemistry using Ki-67 and p53 biomarkers","volume":"25","author":"Apostolou","year":"2014","journal-title":"Cytopathology"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.anndiagpath.2007.05.005","article-title":"Utility of thin-layer preparations in the endometrial cytology: evaluation of benign endometrial lesions","volume":"12","author":"Norimatsu","year":"2008","journal-title":"Ann Diagn Pathol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1576060\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:13:37Z","timestamp":1745799217000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1576060\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":43,"alternative-id":["10.3389\/fmed.2025.1576060"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1576060","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,28]]},"article-number":"1576060"}}